title: Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults.
abstract: Purified polysaccharide and conjugate vaccines are widely used for preventing infections in adults and in children against the Gram-positive bacterium Streptococcus pneumoniae, a pathogen responsible for high morbidity and mortality rates, especially in developing countries. However, these polysaccharide-based vaccines have some important limitations, such as being serotype-dependent, being subjected to losing efficacy because of serotype replacement and high manufacturing complexity and cost. It is expected that protein-based vaccines will overcome these issues by conferring a broad coverage independent of serotype and lowering production costs. In this study, we have applied the "shaving" proteomic approach, consisting of the LC/MS/MS analysis of peptides generated by protease treatment of live cells, to a collection of 16 pneumococcal clinical isolates from adults, representing the most prevalent strains circulating in Spain during the last years. The set of unique proteins identified in all the isolates, called "pan-surfome", consisted of 254 proteins, which included most of the protective protein antigens reported so far. In search of new candidates with vaccine potential, we identified 32 that were present in at least 50% of the clinical isolates analyzed. We selected four of them (Spr0012, Spr0328, Spr0561 and SP670_2141), whose protection capacity has not yet been tested, for assaying immunogenicity in human sera. All of them induced the production of IgM antibodies in infected patients, thus indicating that they could enter the pipeline for vaccine studies. The pan-surfomic approach shows its utility in the discovery of new proteins that can elicit protection against infectious microorganisms.
authors.affiliation: Departamento de Bioquímica y Biología Molecular, Universidad de Córdoba, Campus de Excelencia Internacional CeiA3, Hospital Universitario Reina Sofía, Córdoba, Spain.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Olaya-Abril
authors.forename: Irene
authors.initials: I
authors.lastname: Jiménez-Munguía
authors.forename: Lidia
authors.initials: L
authors.lastname: Gómez-Gascón
authors.forename: Ignacio
authors.initials: I
authors.lastname: Obando
authors.forename: Manuel J
authors.initials: MJ
authors.lastname: Rodríguez-Ortega
mesh_terms: D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood; D000942:Antigens, Bacterial / Q000737:chemistry / Q000276:immunology* / Q000302:isolation & purification; D002853:Chromatography, Liquid; D006801:Humans; D008565:Membrane Proteins / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D010447:Peptide Hydrolases / Q000378:metabolism; D011008:Pneumococcal Infections / Q000382:microbiology*; D022242:Pneumococcal Vaccines / Q000592:standards*; D013296:Streptococcus pneumoniae / Q000737:chemistry / Q000276:immunology*; D053719:Tandem Mass Spectrometry
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D008565:Membrane Proteins; D022242:Pneumococcal Vaccines; D010447:Peptide Hydrolases
references.citation: Trends Biotechnol. 2001 May;19(5):181-8
references.pmid: 11301131
references.citation: Nat Biotechnol. 2006 Feb;24(2):191-7
references.pmid: 16415855
references.citation: Infect Immun. 2001 Mar;69(3):1593-8
references.pmid: 11179332
references.citation: Methods Biochem Anal. 2006;49:379-93
references.pmid: 16929688
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12907-12
references.pmid: 17644611
references.citation: Proteomics. 2010 Sep;10(17):3082-96
references.pmid: 20662103
references.citation: Microb Pathog. 1988 Dec;5(6):461-7
references.pmid: 3149709
references.citation: Lancet. 2011 Dec 3;378(9807):1962-73
references.pmid: 21492929
references.citation: J Infect Dis. 1997 Apr;175(4):839-46
references.pmid: 9086139
references.citation: N Engl J Med. 2006 Apr 6;354(14):1455-63
references.pmid: 16598044
references.citation: Infect Immun. 1980 Feb;27(2):444-8
references.pmid: 6991416
references.citation: Clin Exp Immunol. 2004 Nov;138(2):290-8
references.pmid: 15498039
references.citation: Vaccine. 2006 Jun 12;24(24):5133-9
references.pmid: 16707196
references.citation: Infect Immun. 2002 May;70(5):2526-34
references.pmid: 11953392
references.citation: Infect Immun. 2000 Jul;68(7):4180-8
references.pmid: 10858235
references.citation: Rev Panam Salud Publica. 2009 Apr;25(4):337-43
references.pmid: 19531322
references.citation: Infect Immun. 2009 Jul;77(7):2957-61
references.pmid: 19433540
references.citation: Infect Immun. 2008 Jun;76(6):2767-76
references.pmid: 18391008
references.citation: Vaccine. 2006 Mar 10;24(11):1868-73
references.pmid: 16316712
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9
references.pmid: 23051612
references.citation: Lancet Infect Dis. 2005 Feb;5(2):83-93
references.pmid: 15680778
references.citation: Microbiol Mol Biol Rev. 1999 Mar;63(1):174-229
references.pmid: 10066836
references.citation: J Exp Med. 2008 Jan 21;205(1):117-31
references.pmid: 18166586
references.citation: J Proteomics. 2012 Jun 27;75(12):3733-46
references.pmid: 22575384
references.citation: Infect Immun. 1994 Dec;62(12):5683-8
references.pmid: 7960154
references.citation: Infect Immun. 2007 Feb;75(2):1059-62
references.pmid: 17145945
references.citation: PLoS One. 2011;6(12):e28547
references.pmid: 22216100
references.citation: Proteomics. 2010 May;10(10):2037-49
references.pmid: 20217865
references.citation: PLoS One. 2010 Jul 16;5(7):e11634
references.pmid: 20661294
references.citation: PLoS Med. 2010 Oct 05;7(10):
references.pmid: 20957191
references.citation: Thorax. 2012 Jan;67(1):71-9
references.pmid: 20729232
references.citation: Cell Host Microbe. 2011 Feb 17;9(2):158-65
references.pmid: 21320698
references.citation: PLoS One. 2012;7(8):e42595
references.pmid: 22912711
references.citation: Vaccine. 2010 Jul 12;28(31):4955-60
references.pmid: 20576535
references.citation: Lancet. 2009 Sep 12;374(9693):893-902
references.pmid: 19748398
references.citation: Microbiology (Reading). 1998 Nov;144 ( Pt 11):3049-3060
references.pmid: 9846740
references.citation: Mol Microbiol. 2005 Dec;58(5):1430-40
references.pmid: 16313627
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15641-6
references.pmid: 16223875
references.citation: J Proteomics. 2010 Nov 10;73(12):2365-9
references.pmid: 20656083
references.citation: Infect Immun. 2011 Sep;79(9):3697-710
references.pmid: 21768284
references.citation: PLoS One. 2012;7(5):e36588
references.pmid: 22570729
references.citation: J Microbiol. 2010 Dec;48(6):872-6
references.pmid: 21221949
references.citation: Microbes Infect. 2008 Nov-Dec;10(14-15):1536-42
references.pmid: 18930162
references.citation: Clin Microbiol Infect. 2012 Aug;18(8):756-62
references.pmid: 21851490
references.citation: Emerg Infect Dis. 2008 Sep;14(9):1390-7
references.pmid: 18760005
references.citation: Microb Pathog. 1996 Jul;21(1):17-22
references.pmid: 8827703
references.citation: PLoS One. 2011 Apr 14;6(4):e18649
references.pmid: 21533186
references.citation: J Infect Dis. 2008 Aug 1;198(3):375-83
references.pmid: 18507531
references.citation: Clin Microbiol Infect. 2012 Oct;18 Suppl 5:25-36
references.pmid: 22862432
references.citation: Infect Immun. 2011 Jan;79(1):238-45
references.pmid: 20956575
references.citation: Infect Immun. 2004 Jul;72(7):3902-6
references.pmid: 15213133
references.citation: Vaccine. 2010 Apr 30;28(20):3609-16
references.pmid: 20079873
references.citation: Pediatr Infect Dis J. 2012 Mar;31(3):228-34
references.pmid: 22330164
references.citation: Infect Dis Clin North Am. 2013 Mar;27(1):229-41
references.pmid: 23398877
references.citation: J Biol Chem. 2006 Jan 13;281(2):968-76
references.pmid: 16260779
references.citation: J Biol Chem. 2010 Mar 5;285(10):7517-24
references.pmid: 20048164
references.citation: J Proteomics. 2012 Oct 22;75(18):5654-66
references.pmid: 22842152
references.citation: J Infect Dis. 2010 Jan 1;201(1):32-41
references.pmid: 19947881
references.citation: Mol Cell Proteomics. 2009 Jul;8(7):1728-37
references.pmid: 19401597
references.citation: Infect Immun. 2005 Feb;73(2):981-9
references.pmid: 15664941
references.citation: Clin Microbiol Infect. 2012 Oct;18 Suppl 5:7-14
references.pmid: 22882668
references.citation: Clin Infect Dis. 2010 Sep 15;51(6):692-9
references.pmid: 20715907
references.citation: Clin Microbiol Infect. 2008 Jan;14(1):74-81
references.pmid: 18034862
references.citation: Clin Microbiol Infect. 2012 Oct;18 Suppl 5:15-24
references.pmid: 22882735
references.citation: OMICS. 2011 Oct;15(10):683-94
references.pmid: 21978396
references.citation: BMC Genomics. 2008 Dec 05;9:588
references.pmid: 19061494
references.citation: Infect Immun. 2006 Oct;74(10):5888-92
references.pmid: 16988268
references.citation: Microb Pathog. 1992 Feb;12(2):137-43
references.pmid: 1350045
references.citation: PLoS One. 2012;7(8):e43619
references.pmid: 22928005
references.citation: Clin Interv Aging. 2012;7:453-61
references.pmid: 23152675
references.citation: Pediatr Infect Dis J. 2008 Aug;27(8):709-12
references.pmid: 18600192